Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
Location status: Recruiting
NCT Number: NCT06880809
The goal of this clinical trial is to develop and preliminarily test a culturally adapted suicide intervention specifically for black youth. The main question it aims to answer:
-To evaluate the feasibility and acceptability of the group, as well as the preliminary efficacy of the group for decreasing suicidal thoughts and behaviors and increasing protective factors such as hope, positive ethnic identity, and family and peer support.
Participants will be asked to attend 10-week group intervention and complete pre-treatment and post-treatment assessment measures.
Interested in participating?
Request Info12 year–17 year
All sexes
Interventional
Not applicable
Los Angeles, California, 90027, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will complete a group intervention, rooted in the Collaborative Assessment & Management of Suicidality (CAMS) evidence-based model, driven by their own unique identification of suicide drivers.
Time frame: From pre-treatment until 3 months post-treatment, approximately 23 weeks.
An assessment of suicide risk that consists of six core assessment constructs: psychological pain, stress, agitation, hopelessness, self-hate, and overall risk of suicide; as well as reasons for living and reasons for dying constructs, and wish to live and wish to die constructs.
Time frame: From baseline until 3 months post-treatment, approximately 22 weeks.
A 17-item scale that assesses the three components of ethnic identity and distinguishes between exploration, resolution, and affirmation. Scores range from 17-68, with higher scores indicating higher levels of affirmation, exploration, and resolution.
Time frame: From baseline until 3 months post-treatment, approximately 22 weeks.
A one-item measure that is prospectively associated with suicidal ideation and suicide attempts by measuring readiness to continue living among individuals thinking of suicide. Scores range from 0-8, with 8 indicating an individual is committed to making changes to make their lives worth living.
Time frame: From baseline until 3 months post-treatment, approximately 22 weeks.
A 6-item self-report scale that measures the suicidal belief system, including dimensions of unlovability, unbearability, and unsolvability. Scores range from 6-30, with lower scores indicating fewer suicide cognitions.
Time frame: From baseline until 3 months post-treatment, approximately 22 weeks.
A 12-item scale that reflects Bordin's three-dimensional conceptualization of therapeutic alliance: task, goal, and bond. Scores range from 12-60, with higher scores indicating higher therapeutic alliance.
Time frame: From baseline until 3 months post-treatment, approximately 22 weeks.
A 14-item scale that measures an individual's level of both optimism, as characterized by a positive outlook on the future, and hope, as characterized by the belief in one's ability to achieve goals and navigate challenges. Scores range from 14-56, with lower scores indicating more hope and optimism.
Time frame: From baseline until 3 months post-treatment, approximately 22 weeks.
A 23-item scale aimed at providing a discharge readiness assessment before pediatric discharge from care in hospital settings. Scores range from 0-80, with higher scores indicating more readiness.
Time frame: From baseline until the beginning of post-treatment, approximately 10 weeks.
A 12-item self-report scale that measures group cohesion, including dimensions of engagement, conflict, and avoidance. Scores across the subscales range from 0-72; higher scores indicate more of that dimension.
Contact information is provided by the study sponsor or research team.
Amy West, PhD
CONTACT
Tia Tyndal, PhD
CONTACT
Children's Hospital Los Angeles
Other
Bridging the Gap: A Collaborative Intervention Group for Black Youth at Risk for Suicide
Acronym: Bridge the Gap
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06466356
Behavior, Behavioral Symptoms
Levanger, Trøndelag, Norway
View Trial DetailsNCT07401940
Behavior, Behavioral Symptoms
New York, United States
View Trial DetailsNCT06499740
Behavior, Behavioral Symptoms
Centralia, Washington, United States
View Trial DetailsNCT06151158
Behavior, Behavioral Symptoms
St. Petersburg, Florida, United States
View Trial Details